Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for Premier Medical COVID-19 Test

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for Premier Medical Laboratory Services' PCR-based SARS-CoV-2 assay.

The PMLS SARS-CoV-2 Assay is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in anterior nasal swab specimens collected using the INeedaCOVID19Test.com Self Collection Kit.

Testing with the assay is limited to Greenville, South Carolina-based Premier Medical, according to the FDA.

In December 2020, Premier Medical partnered with TNG Dx to develop a rapid RNA extraction protocol for use with SARS-CoV-2 diagnostics.

The Scan

Omicron's Sewage Path

The New York Times writes that testing sewage is helping public health officials track Omicron.

IBM Sells Part of Watson Health

The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm.

Identifying the Right Whales

The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought.

Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer

In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.